Showing results (111-120 of 138) with videos related to
Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastasesC Carlomagno, F Perrone, C Gallo, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?F Perrone, C Carlomagno, R Lauria, et al.Cancer|August 30, 2000
Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomasS Pepe, A Ruggiero, M D'Acquisto, et al.Anticancer Research|March 28, 2001
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancerS De Placido, S Tramontana, E Ferrari, et al.British Journal of Haematology|August 29, 1998
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cellsA Leardi, M Caraglia, C Selleri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-upS De Placido, C Carlomagno, F Ciardiello, et al.Anticancer Research|March 1, 1997
A phase II study of VM-26 plus lonidamine in pretreated small cell lung cancerC Gridelli, F De Marinis, A Rossi, et al.Oncology Reports|October 19, 1999
TAG-72 expression and clinical outcome in primary breast cancerC Pizzi, A Sgambato, M De Laurentiis, et al.Oncology|October 17, 2002
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 studyC Carlomagno, R Lauria, M De Laurentiis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotidesN Normanno, C Bianco, V Damiano, et al.Pageof 14